Cardiac implantable electronic devices are advanced heart failure therapies, delivered by
specialists, that require continuing management from a multidisciplinary team including …

Cardiac implantable electronic devices are advanced heart failure therapies, delivered by
specialists, that require continuing management from a multidisciplinary team including …

Cardiac implantable electronic devices (CIEDs) are essential for the management of a
variety of cardiac conditions, including tachyarrhythmias, bradyarrhythmias, and medically …

Reducing heart failure hospitalizations represents a major challenge for modern clinicians.
Early detection of congestion plays a key role in disease management strategy. Apart from …

Opinion statement Heart failure is one of the most common medical problems faced by
patients and clinicians. It has the potential for high morbidity and mortality, and its overall …

Heart failure is a disease characterized by marked morbidity and mortality, and caring for
these patients is never an easy task. One of the treatment goals is to monitor heart failure …

Opinion statement Congestive heart failure (CHF) affects more than 5 million people in the
United States and is one of the most common reasons for recurrent hospitalizations. Since …

Heart failure is a difficult and costly disease to manage in part because the symptoms may
be protean, the physical findings obscure, and the laboratory assessments unreliable. New …

Although pharmacologic therapy has made impressive advances in the past decade and is
the mainstay of therapy for heart failure (HF), there is still a large unmet need, because …

Heart failure (HF) decompensation continues to account for approximately 1 million
hospitalizations per year in the United States. Pulmonary congestion is the hallmark sign of …